Standard Biotools Inc. (lab 2.75 02/01/34)
13F holders, Q1 2025 (March 31)3holders
1new positions
1sold out
$0.99avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Standard Biotools Inc. (lab 2.75 02/01/34) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Envestnet Asset Management Inc. ($20K), Mariner, LLC ($10K) and NewEdge Advisors, LLC ($987).
- Company
- Standard Biotools Inc. (lab 2.75 02/01/34)
- CUSIP
- 34385PAA6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $987 |
| Exits | 1 | $791K |
All 13F filers, Q4 2024 → Q1 2025: 1,000 shares bought and 8,000 shares sold, net −7,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Envestnet Asset Management Inc. | 0.00% | No change | 20,000 | $20K |
| Mariner, LLC | 0.00% | No change | 10,000 | $10K |
| NewEdge Advisors, LLC | 0.00% | New | 1,000 | $987 |
"% of holder's portfolio" is STANDARD BIOTOOLS INC (LAB 2.75 02/01/34)'s weight in each manager's 13F, not the share of Standard Biotools Inc. (lab 2.75 02/01/34) the manager owns.